via National Human Genome Research Institute
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has the potential to protect us against serious life-limiting diseases such as cancer and dementia
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has uncovered an important regulatory mechanism to keep our genome healthy. This pathway has the potential to protect us against serious life-limiting diseases such as cancer and dementia.
Cancer and neurodegeneration are two major health challenges currently affecting the population, and they constitute two sides of the same coin – one is caused by uncontrolled cell proliferation due to genome damage, and the other is caused by excessive genome damage that causes cell death. This new pathway impacts both and offers new therapeutic opportunities to help the fight against disease.
Published in Nature Communications, the research found that when cells in our body read DNA to build proteins, they often make mistakes that can damage our genome, causing disease such as cancer and dementia. However, by investigating how cells fix damage in the DNA to keep us healthy, scientists have discovered the benefits of three proteins working together as a team. The three proteins, called USP11, KEAP1 and SETX, receive instructions from their coach to direct their function in space and time with remarkable harmony, to keep our DNA healthy.
By understanding how cells protect themselves from these mistakes and thus preventing diseases, scientists are able to modify the behaviour of these proteins to promote the health and wellbeing of people.
Findings from this study will enable scientists to develop diagnostic tests and drugs to target one or more of the proteins in the pathway for the early detection and treatment of certain types of cancer and neurological disease. Developing new drugs to regulate the level of one or more of these proteins is expected to offer new treatments for cancer and dementia.
The findings are important and significant, this is because we are now at the stage where we could make drugs to control this modification. This would be useful in killing cells, which is what we do when we treat elderly people for cancer. The other application would be to reduce the level of genome damage, which could be beneficial for other ageing associated disorders like dementia.
Original Article: New gene therapy pathway could protect us from cancer and dementia
More from: University of Sheffield
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Gene therapy pathway
- Nutrient research reveals pathway for treating brain disorderson May 1, 2024 at 6:40 pm
The team discovered that an essential nutrient called choline is transported into the brain, across the blood-brain barrier, by a protein transporter called FLVCR2. This is discovery will inform ...
- U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia Bon April 26, 2024 at 7:45 am
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the ...
- Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per doseon April 26, 2024 at 7:19 am
Ten years after dipping its toe into the gene therapy pool in a licensing deal with Spark Therapeutics, Pfizer has gained an FDA approval for the acquired treatment. | Ten years after dipping its toe ...
- NIH Reports a Gene-Based Therapy Restores Cellular Development and Function in Brain Cells from People with Timothy Syndromeon April 25, 2024 at 8:00 am
NIH Reports a Gene-Based Therapy Restores Cellular Development and Function in Brain Cells from People with Timothy Syndrome ...
- Gene-based therapy restores cellular development and function in brain cells from people with Timothy syndromeon April 23, 2024 at 5:00 pm
In a proof-of-concept study, researchers demonstrated the effectiveness of a potential new therapy for Timothy syndrome, an often life-threatening and rare genetic disorder that affects a wide range ...
Go deeper with Google Headlines on:
Gene therapy pathway
[google_news title=”” keyword=”gene therapy pathway” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Gene therapy
- Demand grows for outsourced cell therapy manufacturingon May 1, 2024 at 2:55 pm
In latest deal, Bristol Myers Squibb picks Cellares to manufacture its chimeric antigen receptor T-cell therapies for cancers ...
- Ocugen to Present Pioneering Gene Therapy Data at Retinal Innovation Summiton April 30, 2024 at 1:00 pm
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company, announced that Dr. Benjamin Bakall will present findings from the OCU400 Phase 1/2 clinical trials at the upcoming Retinal Cell ...
- Invest In A Revolutionary Gene Therapy With CRISPR Therapeuticson April 30, 2024 at 10:25 am
CRISPR Therapeutics' Casgevy could generate significant shareholder value if proven to be successful. Learn why I am highly bullish on CRSP stock.
- OSU researchers pioneer technique for delivering gene therapy to specific brain areason April 30, 2024 at 2:00 am
Researchers say the procedure holds promise for a host of genetic neurological disorders, including Parkinson's, Alzheimer's, multiple system atrophy (ASA) and more.
- What Lies Ahead? Shaping the Future of Cell and Gene Therapyon April 29, 2024 at 1:24 pm
Sponsored content brought to you by The launch of Revvity, Inc. in May 2023 signaled the rebranding of an 85-year-old company with a dedicated focus on the diagnostics and life sciences sector.
Go deeper with Google Headlines on:
Gene therapy
[google_news title=”” keyword=”gene therapy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]